Evolva Holding S.A.
Evolva Holding S.A. (ELVAY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
elvay · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Evolva Holding S.A. (ELVAY) measures how much investors pay for each dollar of the company's trailing earnings. ELVAY's current PE ratio of N/A is calculated by dividing its stock price of $1.16 by its TTM earnings per share of -$0.09.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Evolva Holding S.A.You ELVAY | $1M | N/A | — | -$0.09 |
 Alseres Pharmaceuticals, Inc. ALSE | $0M | N/A | — | -$153.75 |
 Claritas Pharmaceuticals, Inc. CLAZF | $0M | 0.00x | — | $0.16 |
 HCYTD HCYTD | — | N/A | — | — |
 TuHURA Biosciences, Inc. HURA | $130M | N/A | — | -$0.63 |
 Laxai Pharma, Ltd. LAXAF | $0M | N/A | — | — |
 Lotus Ventures Inc. LTTSF | $0M | N/A | — | -$0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 1302.74x | $0.14 | — | |
2023-12-31 FY2023 | — | $-14.59 | — | |
2022-12-31 FY2022 | — | $-10.13 | — | |
2021-12-31 FY2021 | — | $-11.72 | — | |
2020-12-31 FY2020 | — | $-9.49 | — | |
2019-12-31 FY2019 | — | $-7.02 | — | |
2018-12-31 FY2018 | — | $-9.48 | — | |
2017-12-31 FY2017 | — | $-20.22 | — | |
2016-12-31 FY2016 | — | $-18.91 | — | |
2015-12-31 FY2015 | — | $-18.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Evolva Holding S.A. (ELVAY) measures how much investors pay for each dollar of the company's trailing earnings. ELVAY's current PE ratio of N/A is calculated by dividing its stock price of $1.16 by its TTM earnings per share of -$0.09.
Frequently asked questions
ELVAY pe ratio · 6 questionsELVAY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.16 and TTM EPS of -$0.09. Data sourced from Financial Modeling Prep via ELVAY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Evolva Holding S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09